Vergoeding 2019-2023 voor ATC-subgroep N06AB : Selectieve serotonine-heropnameremmers
- Raming voor de totale Zvw-populatie
| 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|
| N06AB03 Fluoxetine (Prozac ®) | 1.001.600 | 1.560.900 | 1.233.800 | 1.361.100 | 1.759.400 |
| N06AB04 Citalopram (Cipramil ®) | 3.873.300 | 3.882.200 | 3.401.300 | 3.682.100 | 3.528.300 |
| N06AB05 Paroxetine (Seroxat ®) | 3.894.700 | 4.229.900 | 4.325.800 | 4.486.400 | 5.250.200 |
| N06AB06 Sertraline (Zoloft ®) | 2.033.600 | 2.086.100 | 2.111.400 | 2.588.900 | 2.674.600 |
| N06AB08 Fluvoxamine (Fevarin ®) | 755.020 | 762.540 | 819.430 | 773.570 | 877.880 |
| N06AB10 Escitalopram (Lexapro ®) | 1.709.700 | 2.035.200 | 2.084.100 | 2.236.000 | 2.444.800 |
| Totaal | 13.267.920 | 14.556.840 | 13.975.830 | 15.128.070 | 16.535.180 |